Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bay Area's Nektar Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly July 23, 2017 Acorda Plunges After the FDA Rejects Marketing App for Parkinson's Disease Drug August 28, 2017 AstraZeneca PLC CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo July 20, 2017
AstraZeneca PLC CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo July 20, 2017